Lack of standardization in exception points for patients with primary sclerosing cholangitis and bacterial cholangitis.

ACG Clinical Guideline: Primary Sclerosing Cholangitis. Am J Gastroenterol (2015) 1.58

Risk of waitlist mortality in patients with primary sclerosing cholangitis and bacterial cholangitis. Liver Transpl (2013) 1.52

Liver Transplantation for Cholestatic Liver Diseases in Adults. Clin Liver Dis (2015) 0.88

Standardizing MELD Exceptions: Current Challenges and Future Directions. Curr Transplant Rep (2014) 0.84

MELD exceptions for portopulmonary hypertension: current policy and future implementation. Am J Transplant (2014) 0.82

Outcomes of liver transplantation for end-stage biliary disease: A comparative study with end-stage liver disease. World J Gastroenterol (2015) 0.75

Liver transplantation in the United States, 1999-2008. Am J Transplant (2010) 3.92

Liver allocation and distribution: possible next steps. Liver Transpl (2011) 2.14

Model for end-stage liver disease (MELD) exception guidelines: results and recommendations from the MELD Exception Study Group and Conference (MESSAGE) for the approval of patients who need liver transplantation with diseases not considered by the standard MELD formula. Liver Transpl (2006) 1.99

New national liver transplant allocation policy: is the regional review board process fair? Liver Transpl (2004) 1.80

Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl (2011) 1.37

Regional variations in peer reviewed liver allocation under the MELD system. Am J Transplant (2005) 1.31

Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver Transpl (2006) 0.98